单纯监测在睾丸临床I期非精原细胞瘤（NSGCT）治疗中的应用。 - Suppr | 超能文献

Surveillance alone in the treatment of clinical stage I nonseminomatous germ cell tumor of the testis (NSGCT).

作者信息

Sogani P C, Fair W R

机构信息

Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.

出版信息

Semin Urol. 1988 Feb;6(1):53-6.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Surveillance alone in the treatment of clinical stage I nonseminomatous germ cell tumor of the testis (NSGCT).单纯监测在睾丸临床I期非精原细胞瘤（NSGCT）治疗中的应用。

Semin Urol. 1988 Feb;6(1):53-6.

2

Non-risk-adapted surveillance in clinical stage I nonseminomatous germ cell tumors: the Princess Margaret Hospital's experience.临床 I 期非精原细胞瘤生殖细胞肿瘤的非风险适应监测：玛嘉烈公主医院的经验。

Eur Urol. 2011 Apr;59(4):556-62. doi: 10.1016/j.eururo.2010.12.010. Epub 2010 Dec 22.

3

Management of clinical stage I nonseminomatous germ-cell testis tumors.临床I期非精原细胞性生殖细胞睾丸肿瘤的管理

Expert Rev Anticancer Ther. 2003 Feb;3(1):21-30. doi: 10.1586/14737140.3.1.21.

4

Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British Columbia.在不影响临床 I 期以胚胎性为主的非精原细胞性睾丸癌治愈效果的前提下尽量减少治疗：来自不列颠哥伦比亚省的一项基于人群的分析。

J Urol. 2005 Dec;174(6):2209-13, discussion 2213. doi: 10.1097/01.ju.0000181810.22617.f8.

5

Surveillance in stage I nonseminomatous germ cell tumours of the testis.睾丸I期非精原细胞性生殖细胞肿瘤的监测

BJU Int. 2009 Nov;104(9 Pt B):1351-6. doi: 10.1111/j.1464-410X.2009.08858.x.

6

The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor.临床分期为Ⅰ期非精原细胞性生殖细胞肿瘤化疗后淋巴结清扫的指征。

Cancer. 2008 Feb 15;112(4):800-5. doi: 10.1002/cncr.23233.

7

The results of the treatment of stage I and II nonseminomatous germinal testicular tumors.

Turk J Pediatr. 1984;26(1-4):291-6.

8

Outcomes of surveillance protocol of clinical stage I nonseminomatous germ cell tumors-is shift to risk adapted policy justified?临床I期非精原细胞瘤性生殖细胞肿瘤监测方案的结果——转向风险适应性策略是否合理？

J Urol. 2006 Oct;176(4 Pt 1):1424-29; discussion 1429-30. doi: 10.1016/j.juro.2006.06.012.

9

Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only.非精原细胞性生殖细胞睾丸肿瘤临床I期：与仅采用监测策略的治疗方法相比的差异化治疗方法。

Neoplasma. 2007;54(5):437-42.

10

The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.对临床I期非精原细胞性生殖细胞睾丸肿瘤患者进行观察的理由。

Semin Urol. 1993 May;11(2):92-8.

引用本文的文献

1

Complications of primary retroperitoneal lymph-node dissection for low-stage testicular cancer.

World J Urol. 1994;12(3):139-42. doi: 10.1007/BF00192272.

2

Stage I nonseminomatous germ-cell testicular cancer--management options and risk-benefit considerations.I期非精原细胞性生殖细胞睾丸癌——治疗选择及风险效益考量

World J Urol. 1994;12(4):170-6; discussion 177. doi: 10.1007/BF00185665.